ArticleJournal of Taibah University Medical Sciences2025
Comprehensive bibliographic study of the framework of complex generic drugs.
Article in Journal of Taibah University Medical Sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Recently, extensive growth in bibliometric analysis has been observed. The demand for generic drugs has markedly increased in the past three decades, and the market appears to be saturated. Consequently, pharmaceutical companies are focusing on complex generics to improve patient demand and economic growth. This article highlights current research trends in generic and complex generic drugs through bibliometric analysis. Method: All documents from 2013 to 2023 associated with generics and complex generics were retrieved from the Scopus database. After application of the inclusion criteria, 144,015 articles on generics and 84 articles on complex generics were chosen for inclusion. Microsoft Excel and VOSviewer software were used to represent detailed studies and data on complex generics. Results: Publications associated with generic and complex drug products were identified, examined, compared, and summarized, to provide insights into trends and the future research scope. The number of obtained articles clearly indicated that the number of publications on generics is becoming saturated, whereas the number of complex generic studies is markedly increasing. The top regulated and semi regulated markets are now highly focused on complex generics. Concordantly, regulated markets such as those in the United States have funded more complex generics than simple generics. According to cluster analysis, studies on simple generics frequently focused on quality of life. In contrast, the clusters of studies on complex generics indicated challenges at various stages, thus shedding light on the growth of this field. Conclusion: This study provides a comprehensive bibliographic overview of the development of complex generic drugs and market growth. Researchers are currently more focused on complex generics than generics. A global revolution in pharmaceutical science can be expected if all stakeholder experts collaborate and focus on generic version of complex drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.